Morgan Stanley (NYSE:MS) analyst Ricky Goldwasser maintained a Buy rating on Molina Healthcare (NYSE:MOH) on Tuesday, setting a price target of $296, which is approximately 11.48% above the present share price of $265.52.
Goldwasser expects Molina Healthcare to post earnings per share (EPS) of $3.20 for the third quarter of 2021.
The current consensus among 5 TipRanks analysts is for a Moderate Buy rating of shares in Molina Healthcare, with an average price target of $287.75.
The analysts price targets range from a high of $315 to a low of $256.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $6.8 billion and a net profit of $273 million. The company's market cap is $15.51 billion.
According to TipRanks.com, Morgan Stanley analyst Ricky Goldwasser is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 18.8% and a 67.48% success rate.
Molina Healthcare, Inc. engages in the provision of health care services. It operates through the Health Plans and Other segments. The Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico and includes direct delivery business. The Other segment includes the historical results of the MMIS and behavioral health subsidiaries. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.